XML 146 R122.htm IDEA: XBRL DOCUMENT v3.21.2
Share Based Compensation (RSU Activity) (Details) - $ / shares
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]      
Vested and expected to vest (shares) 3,189,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted average exercise price, vested and expected to vest (in dollars per share) $ 13.79    
Forfeited (shares) (67,000) (172,000) (511,000)
Weighted average grant date fair value, forfeited (in dollars per share) $ 6.82 $ 4.94 $ 4.38
Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) (1,000) (6,000)  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price $ 16.63 $ 20.60  
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]      
Outstanding at beginning of the period (shares) 750,000 2,002,000  
Granted (shares) 731,000 394,000  
Outstanding at the end of the period (in shares) 1,209,000 750,000 2,002,000
Vested and expected to vest (shares) 1,165,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted average grant date fair value, nonvested, equity instruments other than options, beginning of the period (in dollar per share) $ 17.86 $ 17.45  
Weighted average grant date fair value, granted (in dollars per share) 25.98 23.05  
Weighted average grant date fair value, nonvested, equity instruments other than options, end of the period (in dollar per share) 22.77 $ 17.86 $ 17.45
Weighted average exercise price, vested and expected to vest (in dollars per share) $ 22.67    
Forfeited (shares) (25,000) (91,000)  
Vested and expected to vest (shares) (240,000) (1,555,000)  
Weighted average grant date fair value, vested and expected to vest (in dollars per share) $ 17.55 $ 18.79  
Weighted average grant date fair value, forfeited (in dollars per share) $ 20.31 $ 15.35  
Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) (7,000)    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price $ 21.22    
Special RSU      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]      
Granted (shares) 469,000    
Outstanding at the end of the period (in shares) 469,000    
Vested and expected to vest (shares) 426,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted average grant date fair value, granted (in dollars per share) $ 16.92    
Weighted average grant date fair value, nonvested, equity instruments other than options, end of the period (in dollar per share) 16.92    
Weighted average exercise price, vested and expected to vest (in dollars per share) $ 16.92